Cargando…
Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice
BACKGROUND: The global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlights the need to develop safe and effective vaccines with a top priority. Multiple vaccine candidates are under development, and several vaccines are cu...
Autores principales: | Gao, Tong, Ren, Yi, Li, Shuangqin, Lu, Xin, Lei, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097247/ https://www.ncbi.nlm.nih.gov/pubmed/33952256 http://dx.doi.org/10.1186/s12934-021-01584-5 |
Ejemplares similares
-
High immune efficacy against different avian influenza H5N1 viruses due to oral administration of a Saccharomyces cerevisiae-based vaccine in chickens
por: Lei, Han, et al.
Publicado: (2021) -
Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice
por: Shin, Sung Jae, et al.
Publicado: (2007) -
A vaccine grade of yeast Saccharomyces cerevisiae expressing mammalian myostatin
por: Zhang, Tingting, et al.
Publicado: (2012) -
Recovery of Saccharomyces cerevisiae CNCM I-3856 in Vaginal Samples of Healthy Women after Oral Administration
por: Decherf, Amelie, et al.
Publicado: (2020) -
Oral Vaccination of Recombinant Saccharomyces cerevisiae Expressing ORF132 Induces Protective Immunity against Cyprinid Herpesvirus-2
por: Wang, Licong, et al.
Publicado: (2023)